Clinical Evaluation of Polycation-based New Dental Desensitizer on Dentin Hypersensitivity
NCT ID: NCT06378255
Last Updated: 2025-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
40 participants
INTERVENTIONAL
2024-03-20
2025-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Dentin Hypersensitivity Reduction Over a 1-month Period
NCT04351412
Efficacy of Remineralizing Products Used in Molar Grooves: Evaluation With Diagnodent Pen and Diagnocam
NCT06425536
Effect of Gluma and Bioactive Glass Desensitizers in Treatment of Dentin Hypersensitivity in Cervical Non-Carious Lesions
NCT07063433
Gluma Compared With Bonding Agent for Post-operative Sensitivity Following Composite Restorations
NCT07188142
Effect of Seashell Nanoparticles and Gluma Desensitizer on Sensitivity of Teeth
NCT06622018
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Polycation-based new dentinal desensitizer
Use a cotton ball or brush to apply a small amount of desensitizing agent to the sensitive tooth surface for about 1 minute and wait for 2 minutes. Excess gel is then wiped off the surface.
Polycation-based new dentinal desensitizer
Dental desensitization treatment
GLUMA desensitizer
Use according to instructions
GLUMA desensitizer
Dental desensitization treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Polycation-based new dentinal desensitizer
Dental desensitization treatment
GLUMA desensitizer
Dental desensitization treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* dentin-sensitive tooth in at least 2 different quadrants of the mouth (neck enamel dentin exposure or maxillofacial abrasion within the middle layer of dentin).
* in good overall health
* participants informed consent.
Exclusion Criteria
* Dental caries, wedge defects, crowns or large fillings.
* Received dentin sensitivity desensitization treatment or used desensitization mouthwash within 1 month.
* Received systematic periodontal therapy or periodontal surgery within 3 months, ongoing orthodontic treatment, and medical treatment, including long-term use of anti-inflammatory, analgesic, and psychotropic medications.
* Pregnancy or breastfeeding.
* Participated in other clinical trials in the past 3 months.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University Hospital of Stomatology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University School and Hospital of Stomatology
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PKUSSIRB-202393160
Identifier Type: OTHER
Identifier Source: secondary_id
Z221100007422088
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
PKUSSNCT-23A04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.